Two new studies investigate the early, potent response of IgA antibodies against SARS-CoV-2
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system’s first responders. The finding may also inform the development…
Details